TY  - JOUR
T1  - Cases of cutaneous anthrax in eastern Turkey: The reports of three cases
AU  - Karadaş, Sevdegül
AU  - Gönüllü, Hayriye
AU  - Ceylan, Mehmet
AU  - Esmer, Fatih
AU  - Ebinç, Senar
PY  - 2015
DA  - May
JF  - Deneysel ve Klinik Tıp Dergisi
JO  - J. Exp. Clin. Med.
PB  - Ondokuz Mayıs University
WT  - DergiPark
SN  - 1309-4483
SP  - 43
EP  - 45
VL  - 32
IS  - 1
LA  - en
AB  - Anthrax is an acute disease caused by the bacterium Bacillus anthracis. This bacteria canform dormant endospores. When spores are inhaled, ingested, or come into contact witha skin lesion on a host, they may become reactivated multiply and rapidly. B. anthracisbacterial spores are soil-borne. Because of their long lifespan, spores are present globallyand remain at the burial sites of animals killed by anthrax for many decades. Diseasedanimals can spread anthrax to humans, either by direct contact or by consumption of adiseased animal’s flesh. The most frequent clinical type of anthrax is cutaneous anthrax.It presents as a boil-like skin lesion that eventually forms an ulcer with a black center(eschar). Cutaneous anthrax form often within the site of spore penetration between twoand five days after exposure. Until the 20th century, anthrax infections killed thousandsof animals and people worldwide each year. Animal vaccination programs and antibiotictherapy were decreased the number of deaths. But, anthrax is still a problem in lessdeveloped countries. It has been reported that the incidence of disease has decreased inTurkey. However, we present here in three cases of cutaneous anthrax admitted to theemergency department of our hospital within a week.
KW  - Cutaneous anthrax
KW  - Emergency department
KW  - Frequency
KW  - Zoonotic disease
CR  - Akdeniz, N., Calka, O., Ozkol, H.U., Akdeniz, H., 2013. Cutaneous anthrax resulting in renal failure with generalized tissue damage. Cutan. Ocul. Toxicol. 32, 327-329. doi: 10.3109/15569527.2013.768257.
CR  - Baykam, N., Ergonul, O., Ulu, A., Eren, S., Celikbas, A., Eroglu, M., Dokuzoguz, B., 2009. Characteristics of cutaneous anthrax in Turkey. J. Infect. Dev. Ctries. 15, 599-603. doi:10.3855/jidc.551.
CR  - Devrim, I., Kara, A., Tezer, H., Cengiz, A.B., Ceyhan, M., Seçmeer, G., 2009. Animal carcass and eyelid anthrax: A case report. Turk J. Pediatr. 51, 67-68.
CR  - Doganay, M., Metan, G., Alp, E., 2010. A review of cutaneous anthrax and its outcome. J. Infect. Public Health. 3, 98-105. doi: 10.1016/j. jiph.2010.07.004
CR  - Freedberg, I.M., Eisen, A.Z., Wolff, K., Austen, K.F., Goldsmith, L.A., Katz, S.I., 2003. Anthrax. In: Fitzpatrick’s dermatology in general medicine. 6th ed. McGraw-Hill, pp, 1919-1921.
CR  - Kayabas, U., Karahocagil., M.K., Ozkurt, Z., Metan, G., Parlak, E., Bayindir, Y., Kalkan, A., Akdeniz, H., Parlak, M., Simpson, A.J., Doganay, M., 2012. Naturally occurring Cutaneous Anthrax: Antibiotic treatment and outcome. Chemotherapy. 58, 34-43. doi: 10.1159/000335593.
CR  - Lucey, D., 2005. Bacillus anthracis (Anthrax). In: Mandell, G.L., Bennett, J.E., Dolin, R., editors. Principles and practice of infectious diseases. Philadelphia: Elsevier-Churchill Livingstone, pp, 2485-2493.
CR  - Meric, M., Willke, A., Muezzinoglu, B., Karadenizli, A., Hosten, T., 2009. A case of pneumonia caused by Bacillus anthracis secondary to gastrointestinal anthrax. Int. J. Infect. Dis. 13, 456-458. doi: 10.1016/j.ijid.2008.12.008.
CR  - Ozcan, H., Kayabas, U., Bayindir, Y., Bayraktar, M.R., Ay, S., 2008. Evaluation of 23 cutaneous anthrax patients in eastern Anatolia,Turkey: Diagnosis and risk factors. Int. J. Dermatol. 47, 1033-1037. doi: 10.1111/j.1365-4632.2008.03665.x.
CR  - Sirisanthana, T., Brown, A.E., 2002. Anthrax of the gastrointestinal tract. Emerg. Infect. Dis. 8, 649-651. doi: 10.3201/eid0807.020062.
UR  - https://dergipark.org.tr/en/pub/omujecm/issue//217468
L1  - https://dergipark.org.tr/en/download/article-file/190363
ER  -